Heptares Therapeutics
Diana Bahu Logan is an accomplished Senior Scientist at Nxera Pharma, specializing in GPCR Drug Discovery since August 2021. Prior experience includes a role as a Research Scientist at AstraZeneca, focusing on cell biology and protein expression of therapeutic antibodies, and at Ossianix, where research concentrated on the delivery of therapeutics across the blood-brain barrier, encompassing protein expression, purification, and characterization. Diana's background also includes a tenure as a Senior Scientist at BioSyntha Technology Ltd, engaged in biotransformation, metabolite identification, and molecular biology, along with analytical techniques such as HPLC and LCMS. Previous experience at Novacta Biosystems Ltd involved similar research in biotransformation and molecular biology. Educational qualifications were obtained at Aalborg University in Denmark.
This person is not in the org chart
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.